Found review

Paying month to month at Found costs $289 for cash pay. The $169 on its pricing page is a 12-month plan paid up front, which is $2,028 in one charge, and the $99 that leads the page is neither of those: it is the in-network insurance rate, also on the 12-month prepay, and it still sits in front of a per-visit copay Found puts at "typically around $30 for most Found members."

The ladder runs in two columns. Month to month, insurance plans start at $199 and cash-pay plans at $289. Prepay a full year and the insurance column falls to $99 a month and the cash column to $169. Found's own footnote spells that out: "Pricing based on 12-month plans paid up-front. Monthly plans start at $199/mo for insurance and $289/mo for cash-pay." Both headline numbers are written as "starting at" and the page adds "Price varies based on medication, insurance and coverage," so read them as floors, not as a quote for your dose.

What the plan fee buys is one program price that covers both molecules rather than a per-drug sticker. Found prices no compounded molecule separately, and its FAQ says compounded medications are included in the cost of both insurance and cash-pay plans. Titrating up does not move the monthly figure, which matters more than it sounds: on programs that price by dose, month four usually costs more than month one. Brand medication is the exception and Found says so plainly, that branded GLP-1 cost "is billed separately and isn't included in the prices listed above." The pricing page now prints those separate figures, Ozempic at $1100 a month, Mounjaro at about $1100, Wegovy and Zepbound each from $650 a month and up, with Saxenda and Victoza listed as pricing varies.

The medication list is the widest of anything covered here, and it was re-read on 2026-08-28: compounded tirzepatide, compounded semaglutide, Ozempic, Zepbound, Mounjaro, Foundayo, metformin, Contrave, Rybelsus, Saxenda, topiramate, Trulicity, Victoza, Wegovy and zonisamide. Two of those are the reason to look here at all. Foundayo is orforglipron, a pill, and Rybelsus is oral semaglutide, so a reader who will not inject has a real route rather than a waiting list. A clinician who can move you from a compounded vial to a brand pen to a tablet without changing platforms is the product being sold.

One conflict on Found's own site is worth knowing before you sign anything. The offer terms at /terms/offer-terms-pricing-v2 never mention $169, $289 or $2,028. They document a different set of plans: a CORE plan at "$129 (plus applicable taxes) every 30 days," a quarterly plan of "2 equal payments of $348" for $696, a six-month at $594, and a self-pay monthly at $199. Those terms also state that GLP-1 medications and Contrave are not included in any subscription plan fee, so they are not the plans a GLP-1 reader is buying. Two details carry over anyway. Billing "every 30 days" is 12.17 charges in a year, not 12. And $199 is the insurance monthly rate on the pricing page while the terms call $199 the self-pay rate. The figures above are quoted from /plans-and-pricing, which is where pricing now lives, the older /pricing path returns a not-found page.

Coverage is narrower than a flat all-50 line suggests, including the one in the summary above. Found's homepage footnote says prescriptions are "not available in all states," and the insurance selector on the pricing page lists about 41. Nothing on the pages read claims 50. If you are counting on insurance rather than cash pay, check your state in that selector before the intake, because the $99 and the $199 rungs only exist on the insurance side.

Found suits a reader with in-network coverage who wants their clinical visits billed to insurance and a clinician free to move between compounded, brand and oral routes as supply and tolerance change. It suits that reader much less if they want a single all-in number, because the plan fee and the medication are separate line items and no advertised figure is the total. And the cheap rungs are only cheap in exchange for a year decided in advance and paid in one charge; on a month-to-month basis, cash pay here is $289.